Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40H8H | ISIN: BE0974487192 | Ticker-Symbol: TG40
Frankfurt
27.06.25 | 21:43
0,011 Euro
-25,68 % -0,004
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OXURION NV Chart 1 Jahr
5-Tage-Chart
OXURION NV 5-Tage-Chart

Aktuelle News zur OXURION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiOXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC158Leuven, BELGIUM - June 25, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
19.06.OXURION: Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region274Leuven, BELGIUM - June 19, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the signing of a letter of intent (LOI) to acquire 70%...
► Artikel lesen
18.06.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC222Leuven, BELGIUM - June 18, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
OXURION Aktie jetzt für 0€ handeln
12.06.OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC258Leuven, BELGIUM - June 12, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
12.06.OXURION: Oxurion moves forward with the planned acquisition of Axiodis319Leuven, BELGIUM - June 12, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the lifting of the condition precedent relating to the...
► Artikel lesen
11.06.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC212Leuven, BELGIUM - June 11, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
04.06.OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas277Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen
04.06.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC245Leuven, BELGIUM - June 4, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
28.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC271Leuven, BELGIUM - May 28, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
22.05.OXURION: Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025291Leuven, BELGIUM - May 22, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, held its annual shareholders' meeting on May 13, 2025....
► Artikel lesen
20.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC254Leuven, BELGIUM - May 20, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
16.05. OXURION: Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO524Louvain, BELGIUM - May 16, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a...
► Artikel lesen
12.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC271Leuven, BELGIUM - May 12, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
09.05.OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas303Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen
25.04.OXURION: Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025374LEUVEN, BELGIUM - April 25, 2025 - 6:30 pm, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces today that negotiations initiated in July 2024 concerning...
► Artikel lesen
11.04.OXURION: Publication Annual Report - Annual Shareholders' Meeting421Leuven, BELGIUM - April 11, 2025 - 08:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial...
► Artikel lesen
04.04.OXURION: Postponement Annual Shareholders Meeting438Leuven, BELGIUM - April 4, 2025 - 02:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding the financial...
► Artikel lesen
02.04.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC330Leuven, BELGIUM - April 2, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
27.03.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC394Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
27.03.OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC351Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1